STARTUP PROFILE

Thymia

COUNTRY
UK
FOUNDED
2020
CATEGORY
Diagnostics and Assessment
Developing digital biomarkers from speech, video, and gameplay to assess and monitor depression and related mental health conditions.
Visit website →
Market Notes · Biweekly

Track this company

Funding, launches and regulatory moves across the neurotech startup map.

Subscribed. Check your inbox to confirm.

•
Neurofounders Insights
$   Funding   -
Seed
MODALITY
Biomarkers
FORM FACTOR
Software/app
INTERFACE DEPTH
Software
INDICATION
Psychiatry
TARGET USER
Clinicians
REGULATORY STAGE
Investigational
Thymia develops digital biomarkers from speech, video, and gameplay for depression assessment, positioning itself in the multimodal mental-health diagnostics space. Its differentiation is the breadth of behavioral inputs rather than reliance on a single biomarker stream.
•
Mentioned in Market Notes
MOST RECENT COVERAGE
#
11
BCI reaches a new scale
30 September – 13 October 2026

Thymia presented an AI model that screens for type 2 diabetes using a 20-second voice recording. It identified 82% of confirmed cases among 801 participants, but produced a 47% false-positive rate. The results have not been peer-reviewed.

Articles featuring
Thymia
No items found.